[Renin and sodium and the formation of vascular lesions in hypertension].
D000804:Angiotensin II / Q000378:metabolism; D000818:Animals; D001834:Body Water; D002199:Capillary Permeability / Q000187:drug effects; D003900:Desoxycorticosterone / Q000494:pharmacology; D004285:Dogs; D006801:Humans; D006973:Hypertension / Q000150:complications*; D006974:Hypertension, Malignant / Q000378:metabolism; D006977:Hypertension, Renal / Q000378:metabolism; D008901:Mineralocorticoids / Q000494:pharmacology; D009392:Nephrectomy; D051381:Rats; D012078:Renal Artery Obstruction / Q000209:etiology; D012083:Renin / Q000378:metabolism* / Q000494:pharmacology; D012964:Sodium / Q000378:metabolism* / Q000494:pharmacology; D014652:Vascular Diseases / Q000209:etiology*; D014655:Vascular Resistance; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D008901:Mineralocorticoids; D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D003900:Desoxycorticosterone; D012964:Sodium; D012083:Renin
Renin und Natrium und die Entstehung vaskulärer Läsionen bei Hpertonie